News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IVAX Corporation (IVX) Receives Approval Of Ciprofloxacin Tablets


10/19/2005 5:11:43 PM

IVAX Corporation (AMEX:IVX), (LSE:IVX.L) has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ciprofloxacin tablets in 250 mg, 500 mg and 750 mg strengths and tentative approval for the 100 mg strength. This product will be sold through the company's wholly owned subsidiary IVAX Pharmaceuticals, Inc. Ciprofloxacin is the generic equivalent of Cipro(R), which is an antibiotic marketed by Bayer Pharmaceuticals Corporation. U.S. sales of Cipro in the 250 mg, 500 mg and 750 mg dosage strengths were over $1.0 billion in 2003.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES